Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.
Morning Overview on MSN
A new gene-editing treatment just drove back advanced stomach and colon cancers in an early trial — by reprogramming patients’ own immune cells to hunt the tumors
Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, reprogrammed using CRISPR gene editing to attack tumors more aggressively.
UAB Medicine offers liver transplantation as a treatment for metastatic colorectal cancer, expanding access to advanced ...
Treatment costs using advanced medicines for patients with stage 4 cancer are 10 to 50 times more expensive than standard ...
California researchers have identified a possible link between toxin in the gut and increase in cancer cases in people under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results